EYPT EyePoint Pharma: Earnings growth forecast for next year

Corporate company logo of EyePoint Corp (EYPT)

Stable demand for retinal therapy guarantees a predictable cash flow, confirming the current trajectory of EPS forecasts for next year for EyePoint Pharmaceuticals (EYPT). The value of 40.60 indicates the level of this metric. Growth is based on the success of YUTIQ and EYP-1901 trials. Meanwhile, strict FDA oversight and patent protection for microinjections create a significant barrier to entry for new players in ophthalmology.

EYPT - EyePoint Pharmaceuticals Inc Expected net earnings per share growth next year over the range 07/04/2022 - 11/12/2026

eyepointpharma.com (EYPT) - metric breakdowns and financial figures

- price and consensus price forecast:
Price Chart EyePoint Pharma|EYPT - Analyst Median Target
- company stock capitalization data:
Market Capitalization EyePoint Pharmaceuticals|EYPT - Total Enterprise Value
- book capitalization indicators:
Accounting Value per Share EyePoint Pharmaceuticals|EYPT - Total Stockholders' Equity|Market Capitalization to Book Value Ratio eyepointpharma.com|EYPT - Company Assets
- issuer credit burden and liquidity indicators:
Debt to Equity EyePoint Pharmaceuticals|EYPT - Long-Term Liabilities to Equity|Short-Term Debt to Equity EyePoint Pharmaceuticals, Inc.|EYPT - Company Cumulative Debt|Debts to Book Capitalization EyePoint Pharmaceuticals|EYPT - Long-Term Debt Volume|Company Short-Term Debt EyePoint Pharmaceuticals|Quick Liquidity Indicator eyepointpharma.com
- earnings and market ratios statistics:
EYPT - Profit After Payment of Taxes|Future Profit EyePoint Pharmaceuticals|EYPT - Company Value to Net Income|Future Price to Earnings EyePoint Pharmaceuticals|EYPT - Market Cap to Earnings and Growth Ratio|EV/EBITDA Multiple EyePoint Pharmaceuticals|EYPT - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) EyePoint Pharmaceuticals|EYPT - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months eyepointpharma.com|EYPT - Earnings per share increase in current year|Net earnings per share growth forecast for next year EyePoint Pharmaceuticals
Fundamental company analysis:EyePoint Pharma, EYPT
Core merchandise of EyePoint Pharmaceuticals, Inc.

To separate fundamental stability from market noise, capital focuses on projected earnings dynamics, which measure the expected rate of value generation for the coming year. By analyzing the forward net income growth rate, investors assess the scaling efficiency of EyePoint Pharmaceuticals (EYPT), where the predictability of revenues from proprietary ophthalmological systems confirms the potential to achieve these ambitious financial goals.

Competitor analysis

Net earnings per share growth forecast for next year Alcon Vision|Bausch Health (BLCO) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year GKOS|APLS - Expected net earnings per share growth next year|Belite Bio Inc - Expected earnings per share growth for next year|Ocular Therapeutix Inc (OCUL) - Expected net earnings per share growth next year|Harrow Health - Earnings growth forecast for next year|Expected net earnings per share growth next year Viridian Corp|LENZ Therapeutics, Inc. (LENZ) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year OCS (Oculis)|Net earnings per share growth forecast for next year Kodiak Sciences|Expected net earnings per share growth next year Aldeyra ALDX|Earnings growth forecast for next year KALA|Consensus forecast of earnings per share growth for next year opusgtx.com|Net earnings per share growth forecast for next year OKYO Pharma OKYO|ADVM: Projected earnings per share growth rate for next year|OTLK: Expected earnings per share growth for next year|Clearside Biomedical Inc - Projected earnings per share increase next year|NBY (novabay.com) - Expected earnings per share growth for next year|Kiora Pharmaceuticals, Inc. - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Alimera Sciences Inc|Eyenovia Corp - Net earnings per share change forecast for next year|Earnings growth forecast for next year GHSI|OCUP (Ocuphire Pharma Inc) - Expected earnings per share trend next year|Earnings growth forecast for next year OPT (Opthea Ltd.)